查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842312

兽医再生医学市场规模、份额和趋势分析报告：按动物、产品、最终用途、地区和细分市场预测，2025-2033年

Veterinary Regenerative Medicine Market Size, Share & Trends Analysis Report By Animal (Small Animals, Large Animals), By Product (Stem Cells, Others), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

兽医再生医学：市场概览

全球兽医再生医学市场预计在 2024 年达到 3.3686 亿美元，预计到 2033 年将达到 9.8785 亿美元，2025 年至 2033 年的复合年增长率为 12.94%。

该市场的发展受到以下因素的推动：动物慢性病和退化性疾病的日益普遍、干细胞和基因治疗技术的进步、宠物日益人性化以及人们愿意为先进的医疗保健付费。

伴侣动物和家畜中慢性、退化性和与老龄化相关的疾病（如骨关节炎、髋关节发育不良、肌腱损伤和脊椎疾病）的发病率不断上升，推动了对动物再生医学的需求。

骨关节炎（OA）是伴侣动物跛行和关节疾病的主要原因，占80%，且由于肥胖和寿命延长，病例数不断增加。在幼犬中，39.8%的犬隻在X光片上显示患有骨关节炎，23.6%的犬隻表现出临床症状，这凸显了该疾病患病率被低估的情况，以及早期发现以优化治疗效果的必要性。饲主和兽医正在寻求超越症状治疗、解决疾病根本原因的先进治疗方法。干细胞疗法、富血小板血浆（PRP）和组织工程技术可望恢復动物功能、减轻疼痛并提高生活品质。随着饲主对这些益处的认识不断提高，相关疗法的应用正在加速成长，为再生兽医学创造了巨大的发展潜力。

基因疗法和生医材料的突破性进展，以及干细胞分离、培养和递送方法的持续创新，正显着提高动物再生医学的疗效和安全性。例如，欧盟委员会核准了Arti-Cell Forte，这是由勃林格殷格翰和GST公司共同开发的首个基于干细胞的动物用药品，可为马匹跛行提供即用型长期解决方案。细胞活力的提高、标靶递送和微创应用技术的进步，正在扩大小型和大型动物可治疗疾病的范围。这些进展也降低了成本，使更多饲主能够负担得起治疗。此外，兽医临床试验和同侪审查证据的增加，增强了兽医对再生疗法的信心，促进了建议率的提高和市场的长期接受度。

目录

第一章 分析方法和范围

第二章执行摘要

第三章：兽医再生医学市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 兽医再生医学市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析
    • 法律规范
    • 科技趋势分析
    • 定价分析
    • 产品平臺分析
    • 按地区和主要品种分類的动物数量估计（2024 年）

第四章：兽医再生医学市场：按动物类型分類的估算与趋势分析

  • 细分仪表板
  • 兽医再生医学市场：波动分析（按动物类型划分）
  • 兽医再生医学市场规模及趋势分析：依动物种类划分（2021-2033 年）
  • 小动物
  • 大型动物

第五章：兽医再生医学市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 兽医再生医学市场：波动分析（依产品分类）
  • 兽医再生医学市场规模及产品趋势分析（2021-2033）
  • 干细胞
  • 其他的

第六章：动物再生医学市场：按应用分類的估算与趋势分析

  • 细分仪表板
  • 兽医再生医学市场：按应用领域分類的趋势分析
  • 兽医再生医学市场规模及应用趋势分析（2021-2033）
    • 整形外科
    • 创伤/创伤护理
    • 其他的

第七章：动物再生医学市场：依最终用途分類的估算与趋势分析

  • 细分仪表板
  • 兽医再生医学市场：依最终用途分類的变化分析
  • 兽医再生医学市场规模及趋势分析（按最终用途划分）（2021-2033 年）
    • 兽医医院和诊所
    • 兽医研究所

第八章：兽医再生医学市场：区域估算与趋势分析

  • 区域仪錶板
  • 按地区分類的兽医再生医学市场份额（2024 年和 2033 年）
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 卡达
    • 阿曼

第九章 竞争情势

  • 市场参与企业分类
  • 企业市场分析/热力图分析
  • 公司简介
    • Boehringer Ingelheim International GmbH.
    • Zoetis Services LLC
    • Dechra
    • Integra LifeSciences
    • Vetherapy
    • Vetstem, Inc.
    • Ardent
    • Enso Discoveries
    • Animal Cell Therapies, Inc.
    • Vetbiologics
    • Medrego
    • Celavet Inc
    • Strategy Mapping
    • Mergers &Acquisitions
    • Partnerships &Collaborations
    • Product launch
    • Others
  • 其他主要企业名单
Product Code: GVR-4-68040-043-0

Veterinary Regenerative Medicine Market Summary

The global veterinary regenerative medicine market size was estimated at USD 336.86 million in 2024 and is projected to reach USD 987.85 million by 2033, growing at a CAGR of 12.94% from 2025 to 2033. The market is advancing, driven by the rising prevalence of chronic and degenerative diseases in animals, advancements in stem cell and gene therapy technologies, growing humanization of pets, and the willingness to spend on advanced care.

The increasing incidence of chronic, degenerative, and age-related conditions such as osteoarthritis, hip dysplasia, tendon injuries, and spinal disorders in companion and livestock animals is driving demand for veterinary regenerative medicine.

Osteoarthritis (OA) causes 80% of lameness and joint disease in companion animals, with rising cases due to obesity and longer lifespans. In young dogs, 39.8% show radiographic OA and 23.6% clinical signs, emphasizing the underreported prevalence and the need for early detection to optimize treatment outcomes. Pet owners and veterinarians are seeking advanced treatment options beyond symptom management to address the root cause of disease. Stem cell therapy, platelet-rich plasma (PRP), and tissue engineering techniques offer the potential to restore function, reduce pain, and improve quality of life. As awareness of these benefits spreads among pet owners, adoption accelerates, creating strong growth potential in regenerative veterinary healthcare.

An increasing number of innovations in stem cell isolation, culture, and delivery methods, alongside breakthroughs in gene therapy and biomaterials, is significantly enhancing the efficacy and safety of veterinary regenerative medicine. For instance, the European Commission approved Arti-Cell Forte, the first stem cell-based veterinary product, offering a ready-to-use, long-term solution for equine lameness, developed by Boehringer Ingelheim and GST to address the underlying joint inflammation causes. Improvements in cell viability, targeted delivery, and minimally invasive application techniques are expanding the range of treatable conditions in small and large animals. These advancements also lower costs, making treatments more accessible to a wider population of pet owners. In addition, increasing veterinary clinical trials and peer-reviewed evidence are strengthening veterinarians' confidence in regenerative approaches, leading to higher recommendation rates and fostering long-term market adoption.

Global Veterinary Regenerative Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary regenerative medicine market report based on animal, product, application, end use and region:

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Animals
  • Large Animals
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Stem Cells
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Orthopedics
  • Trauma/Wound Care
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals/Clinics
  • Veterinary Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Regenerative Medicine Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic and degenerative diseases in animals
      • 3.2.1.2. Advancements in stem cell and gene therapy technologies
      • 3.2.1.3. Growing humanization of pets and willingness to spend on advanced care
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High treatment costs and limited accessibility
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Regenerative Medicine Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Technology Trend Analysis
    • 3.3.5. Pricing Analysis
    • 3.3.6. Product Pipeline Analysis
    • 3.3.7. Estimated Animal Population by region, key species, 2024

Chapter 4. Veterinary Regenerative Medicine Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Regenerative Medicine Market: Animal Movement Analysis
  • 4.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Animal, 2021 to 2033 (USD Million)
  • 4.4. Small Animals
    • 4.4.1. Small Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Large Animals
    • 4.5.1. Large Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Regenerative Medicine Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Regenerative Medicine Market: Product Movement Analysis
  • 5.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Stem Cells
    • 5.4.1. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Regenerative Medicine Market: By Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Regenerative Medicine Market: By Application Movement Analysis
  • 6.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
    • 6.3.1. Orthopedics
      • 6.3.1.1. Orthopedics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Trauma/Wound Care
      • 6.3.2.1. Trauma/Wound Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Others
      • 6.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Regenerative Medicine Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Regenerative Medicine Market: By End Use Movement Analysis
  • 7.3. Veterinary Regenerative Medicine Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Veterinary Research Institutes
      • 7.3.2.1. Veterinary Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Regenerative Medicine Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Veterinary Regenerative Medicine Market Share, By Region, 2024 & 2033 (USD Million)
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. U.S. Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Canada Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Mexico Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. UK Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Germany Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. France Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Italy Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Spain Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Denmark Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Sweden Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Norway Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Japan Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. China Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. India Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Australia Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. South Korea Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Thailand Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Brazil Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Argentina Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. South Africa Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Saudi Arabia Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. UAE Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Kuwait Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.6. Qatar
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Qatar Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.7. Oman
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Competitive Scenario
      • 8.8.7.3. Oman Veterinary Regenerative Medicine Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Boehringer Ingelheim International GmbH.
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis Services LLC
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Dechra
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Integra LifeSciences
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Vetherapy
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Vetstem, Inc.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Ardent
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Enso Discoveries
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Animal Cell Therapies, Inc.
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Vetbiologics
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Medrego
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Celavet Inc
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Strategy Mapping
    • 9.3.14. Mergers & Acquisitions
    • 9.3.15. Partnerships & Collaborations
    • 9.3.16. Product launch
    • 9.3.17. Others
  • 9.4. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Veterinary Regenerative Medicine Market, by region, 2021 - 2033 (USD Million)
  • Table 3 Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 4 Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 5 Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 6 Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 9 North America Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 11 North America Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 13 U.S. Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 U.S. Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Canada Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 17 Canada Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Canada Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Mexico Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 21 Mexico Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Mexico Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24 Europe Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 26 Europe Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Europe Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 Germany Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 30 Germany Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 31 Germany Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Germany Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 33 UK Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 34 UK Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 35 UK Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36 UK Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 38 France Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 France Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 40 France Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Italy Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 42 Italy Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Italy Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45 Spain Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 46 Spain Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 48 Spain Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 49 Denmark Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 50 Denmark Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 52 Denmark Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 53 Sweden Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 54 Sweden Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 Norway Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 58 Norway Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 60 Norway Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 China Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 67 China Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 68 China Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 69 China Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70 Japan Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 71 Japan Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 72 Japan Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Japan Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74 India Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 75 India Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 76 India Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 77 India Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 78 South Korea Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 79 South Korea Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 81 South Korea Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82 Australia Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 83 Australia Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Australia Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 85 Australia Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 86 Thailand Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 87 Thailand Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Thailand Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90 Latin America Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 92 Latin America Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Latin America Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Brazil Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 96 Brazil Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Argentina Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 100 Argentina Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 102 Argentina Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 103 MEA Veterinary Regenerative Medicine Market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 105 MEA Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 106 MEA Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 107 MEA Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 108 South Africa Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 109 South Africa Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 111 South Africa Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 116 UAE Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 117 UAE Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 119 UAE Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 124 Qatar Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 125 Qatar Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 126 Qatar Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 127 Qatar Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 128 Oman Veterinary Regenerative Medicine Market, by Animal, 2021 - 2033 (USD Million)
  • Table 129 Oman Veterinary Regenerative Medicine Market, by Product, 2021 - 2033 (USD Million)
  • Table 130 Oman Veterinary Regenerative Medicine Market, by Application, 2021 - 2033 (USD Million)
  • Table 131 Oman Veterinary Regenerative Medicine Market, by End Use, 2021 - 2033 (USD Million)
  • Table 132 Company Overview
  • Table 133 Product Benchmarking
  • Table 134 Financial Performance
  • Table 135 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Veterinary Regenerative Medicine Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 Veterinary Regenerative Medicine Market snapshot
  • Fig. 11 Veterinary Regenerative Medicine Market driver impact
  • Fig. 12 Veterinary Regenerative Medicine Market restraint impact
  • Fig. 13 Veterinary Regenerative Medicine animal key takeaways (USD Million)
  • Fig. 14 Veterinary Regenerative Medicine Market: animal, market share 2024 & 2033
  • Fig. 15 Small Animals market, 2021 - 2033 (USD Million)
  • Fig. 16 Large Animals market, 2021 - 2033 (USD Million)
  • Fig. 17 Veterinary Regenerative Medicine Market Product key takeaways (USD Million)
  • Fig. 18 Veterinary Regenerative Medicine Market: Product, market share 2024 & 2033
  • Fig. 19 Stem Cells market, 2021 - 2033 (USD Million)
  • Fig. 20 Others market, 2021 - 2033 (USD Million)
  • Fig. 21 Veterinary Regenerative Medicine market by application: Key takeaways
  • Fig. 22 Veterinary Regenerative Medicine market by application, market share, 2024 & 2033
  • Fig. 23 Orthopedics market, 2021 - 2033 (USD Million)
  • Fig. 24 Trauma/Wound Care market, 2021 - 2033 (USD Million)
  • Fig. 25 Others market, 2021 - 2033 (USD Million)
  • Fig. 26 Veterinary Regenerative Medicine market by End Use: Key takeaways
  • Fig. 27 Veterinary Regenerative Medicine market by End Use, market share, 2024 & 2033
  • Fig. 28 Veterinary hospitals & clinics market, 2021 - 2033 (USD Million)
  • Fig. 29 Veterinary Research Institutes market, 2021 - 2033 (USD Million)
  • Fig. 30 Regional market place: Key takeaways
  • Fig. 31 Regional outlook, 2024 & 2033
  • Fig. 32 North America Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 34 Canada Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 37 UK Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 38 Germany Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 39 France Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 40 Italy Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 41 Spain Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 42 Denmark Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 43 Sweden Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 44 Norway Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 45 Asia Pacific Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 46 Japan Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 47 China Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 48 India Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 49 Australia Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 50 South Korea Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 51 Thailand Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 52 Latin America Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 53 Brazil Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 54 Argentina Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 55 MEA Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 56 South Africa Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 57 Saudi Arabia Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 58 UAE Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 59 Kuwait Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 60 Qatar Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 61 Oman Veterinary Regenerative Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 62 Market participant categorization